Literature DB >> 2848201

Noradrenaline contracts arteries by activating voltage-dependent calcium channels.

M T Nelson1, N B Standen, J E Brayden, J F Worley.   

Abstract

Noradrenaline (NA) regulates arterial smooth muscle tone and hence blood vessel diameter and blood flow. NA apparently increases tone by causing a calcium influx through the cell membrane. Two calcium influx pathways have been proposed: voltage-activated calcium channels and NA-activated calcium-permeable channels that are voltage-insensitive. Although voltage-activated calcium channels have been identified in arterial smooth muscle, voltage-insensitive calcium channels activated by NA have not. We show here that NA contractions of rabbit mesenteric arteries increase with depolarization. The increase parallels the elevation of open-state probability (P0) of single, voltage-dependent calcium channels. The action of noradrenaline can be explained by NA-activating voltage-dependent calcium channels, rather than by opening a second type of channel. We show directly that NA increases the open-state probability of single calcium channels. Thus, in the presence of NA, calcium entry through voltage-dependent calcium channels can regulate smooth muscle tone at physiological membrane potentials. These results may have relevance to pathophysiological conditions such as hypertension.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848201     DOI: 10.1038/336382a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  90 in total

1.  Alteration of the [Ca(2+)](i)-force relationship during the vasorelaxation induced by a Ca(2+) channel blocker SR33805 in the porcine coronary artery.

Authors:  S Ieiri; K Hirano; J Nishimura; S Suita; H Kanaide
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  Muscle KATP channels: recent insights to energy sensing and myoprotection.

Authors:  Thomas P Flagg; Decha Enkvetchakul; Joseph C Koster; Colin G Nichols
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

3.  Alternative splicing modulates diltiazem sensitivity of cardiac and vascular smooth muscle Ca(v)1.2 calcium channels.

Authors:  Heng Yu Zhang; Ping Liao; Jue Jin Wang; De Jie Yu; Tuck Wah Soong
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

4.  Sympathetic neural inhibition of conducted vasodilatation along hamster feed arteries: complementary effects of alpha1- and alpha2-adrenoreceptor activation.

Authors:  Sara J Haug; Steven S Segal
Journal:  J Physiol       Date:  2004-12-02       Impact factor: 5.182

5.  Two phases of the prostaglandin F2 alpha-induced contraction in guinea-pig taenia coli involve different Ca2+ channels.

Authors:  S Usune; T Katsuragi; T Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

6.  Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.

Authors:  F Perez-Vizcaino; O Casis; R Rodriguez; L A Gomez; J Garcia Rafanell; J Tamargo
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

7.  Mechanism of vasorelaxation induced by 3'-hydroxy-5,6,7,4'-tetramethoxyflavone in the rats aortic ring assay.

Authors:  Chu Shan Tan; Mun Fei Yam
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-03-19       Impact factor: 3.000

8.  Role of membrane potential in endothelium-dependent relaxation of guinea-pig coronary arterial smooth muscle.

Authors:  H C Parkington; M A Tonta; H A Coleman; M Tare
Journal:  J Physiol       Date:  1995-04-15       Impact factor: 5.182

9.  Identification of the Ca2+ current activated by vasoconstrictors in vascular smooth muscle cells.

Authors:  C Van Renterghem; M Lazdunski
Journal:  Pflugers Arch       Date:  1994-11       Impact factor: 3.657

10.  An amplifying effect of exogenous and neurally stored 5-hydroxytryptamine on the neurogenic contraction in rat tail artery.

Authors:  C Szabó; J E Hardebo; C Owman
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.